Discontinuation rates of Helicobacter pylori treatment regimens: A meta- analysis

Pharmacotherapy

Volumn 19, Issue 3, 1999, Pages 324-332

  Buring, Shauna M ^c   Winner, Lawrence H ^b   Hatton, Randy C ^a   Doering, Paul L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ANTIBACTERIAL ACTIVITY; DATA BASE; DOSE RESPONSE; DRUG WITHDRAWAL; ERADICATION THERAPY; HELICOBACTER PYLORI; META ANALYSIS; PATIENT COMPLIANCE; REVIEW; TREATMENT INDICATION;

EID: 0033020698     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.4.324.30939     Document Type: Review

References (75)

1. U.S. Department of Health and Human Services. Stomach and duodenal ulcers Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 1995.
2. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
3. Soll AH, for the Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. JAMA 1996;275:622-9.
4. de Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
5. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
6. Wilson A, Henry DA. Meta-analysis. 2. Assessing the quality of published meta-analyses. Med J Aust 1992;156:173-87.
7. Spilker B. Meta-analysis. In: Spilker B, ed. Guide to clinical trials, 1st ed. New York: Raven Press, 1991:793-800.
8. Millar MR, Pike J. Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrob Agents Chemother 1992;36:185-7.
9. Westblom TU, Madan E, Subik MA, Duriex DE, Midkiff BR. Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection. Scand J Gastroenterol 1992;27:249-52.
10. Thijs JC, van Zwet AA, Moolenaar W, Wolfhagen MJ, Huinink J. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects. Am J Gastroenterol 1996;91:93-7.
11. Forne M, Viver JM, Espinos JC, Coll I, Tresserra F, Garau J. Impact of colloidal bismuth subcitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. Am J Gastroenterol 1995;90:718-21.
12. Goh KL, Peh SC, Parasakthi N, Wong NW, Tan KK, Lo YL. Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori. Am J Gastroenterol 1994;89:1789-92.
13. Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeptazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996;91:258-63.
14. Sung JY, Chung SC, Ling KW, et al. Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers. Dig Dis Sci 1996;41:453-7.
15. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
16. Labenz J, Gyenes E, Ruhl GH, Borsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993;34:1167-70.
17. Graham DY, Lew GM, Evans DG, Evans DJ, Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991;115:266-9.
18. Sung JY, Chung SC, Ling TK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42
19. O'Riordan T, Mathai E, Tobin E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990;31:999-1002
20. Hosking SW, Ling TK, Chung SC, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343:508-10.
21. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ 1991;303:1238-40.
22. Laine L, Stein C, Neil G. Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimal" dosing. Am J Gastroenterol 1995:90;1407-10.
23. Al-Assi MT, Cole RA, Karttunen TJ, El-Zimaity H, Genta RM, Graham DY. Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. Am J Gastroenterol 1995;90:1411-14.
24. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
25. Sung JY, Leung VK, Chung SC, et al. Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers. Am J Gastroenterol 1995;90:1424-7.
26. Tefera S, Berstad A, Bang CJ, et al. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996;91:935-41.
27. Porro GB, Lazzaroni M, Bargiggia S, et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol 1996;91:695-700.
28. Bayerdorffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412-17.
29. Al-Assi MT, Genta RM, Karttunen TJ, Cole RA, Graham DY. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol 1995;90:403-5.
30. Graham KS, Malaty H, El-Zimaity HM, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995;90:1415-18.
31. McCarthy C, Patchet S, Collins RM, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995;40:114-19.
32. Labenz J, Stolte M, Blum AL, et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995;37:39-43.
33. Borody TJ, Brandi S, Andrews P, Ferch N, Jankiewicz E, Hyland L. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:33-8.
34. Hosking SW, Ling TK, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992;305:502-4.
35. Labenz J, Gyenes E, Ruhl GH, Borsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993;88:491-4.
36. 2 blocker resistant duodenal ulcers: role of Helicobacter pylori. Gut 1992;33:179-83.
37. Labenz J, Ruhl GH, Bertrams J, Borsch G. Medium-or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. Am J Gastroenterol 1994;89:726-9.
38. Boyd HK, Zaterka S, Eisig JN, et al. Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials. Am J Gastroenterol 1994;89:1505-10.
39. de Boer WA, Driessen WM, Potters HV, Tytgat GN. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993-6.
40. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
41. Borody TJ, George LL, Brandl GS, et al. Helicobacter pylori eradication with doxycydine-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol 1992;27:281-4.
42. Lazzaroni M, Bargiggia S, Sangaletti O, Maconi G, Boldorini M, Porro GB. Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia; a clinical endoscopie study. Dig Dis Sci 1996;41:1589-94.
43. Mantzaris GJ, Hatzis A, Tamvakologos G, et al. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Dig Dis Sci 1993;38:1132-6.
44. Louw JA, Zak J, Lucke W, et al. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scand J Gastroenterol 1992;191(suppl 27):28-31.
45. Labenz J, Stolte M, Domian C, Bertrams J, Borsch G. High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. Digestion 1995;56:14-20.
46. Harris AW, Gummett PA, Logan RP, Ashworth HM, Baron JHY, Misiewicz JJ. Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Aliment Pharmacol Ther 1995;9:201-4.
47. Bell GD, Bate CM, Axon AT, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther 1995;9:513-20.
48. Al-Assi MT, Genta RM, Graham DY. Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1994;8:259-62.
49. Katelaris PH, Patchett SE, Zhang ZW, Domizio P, Farthing MJ. A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1995;9:205-8.
50. Furuta T, Futami H, Arai H, Hanai H, Kaneko E. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori. J Clin Gastroenterol 1995;20(suppl 2):S107-11.
51. Dresner D, Coyle W, Nemec R, Peterson R, Duntemann T, Lawson JM. Efficacy of ciprofloxacin in the eradication of Helicobacter pylori. South Med J 1996;89:775-8.
52. Kohli Y, Kato T, Azuma T, Ho S, Hirai M. Lansoprazole treatment of Helicobacter pylori-positive peptic ulcers. J Clin Gastroenterol 1995;20(suppl 1):S48-51.
53. Katoh M, Asaka M, Kudoh M, Kagaya H, Katagiri M, Takeda H. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori. J Clin Gastroenterol 1995;20(suppl 2):S112-14.
54. Miehlke S, Bayerdorffer E, Lehn N, et al. Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin. Digestion 1995;56:187-93.
55. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxicillin and metronidazole compared with four alternative regimens. Q J Med 1993;86:743-50.
56. 13C-UBT and monoclonal H. pylori antibody testing. J Clin Gastroenterol 1995;20(suppl 2):S118-20.
57. Chen TS, Tsay SH, Chang FY, Lee SD. Triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse: comparison of 1 week and 2 week regimens and recrudescence rates over 12 months. J Gastroenterol Hepatol 1995;10:300-5.
58. Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995;41:5-7.
59. Wang WM, Chen CY, Jan CM, et al. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers. J Formos Med Assoc 1993;92:721-4.
60. 2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori. J Formos Med Assoc 1994;93:368-73.
61. Shirotani T, Okada M, Murayama H, et al. Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan. J Gastroenterol 1996;31:175-81.
62. Kim NY, Oh HS, Jung HM, Wee SH, Choi JH, Lee KH. The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence. Korean J Intern Med 1994;9:72-9.
63. Tucci A, Poli L, Gasperoni S, et al. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol 1994;26:107-10.
64. Lazzaroni M, Maconi G, Bargiggia S, Minguzzi M, Porro G. Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence. Eur J Gastroenterol Hepatol 1995;7:117-19.
65. Labenz J, Stolte M, Ruhl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacler pylori infection. Eur J Gastroenterol Hepatol 1995;7:9-11.
66. Park KN, Hahm JS, Kim HJ. Pharmacological effects of metronidazole + tetracycline + bismuth subcitrate versus omeprazole + amoxicillin + bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Eur J Gastroenterol Hepatol 1994;6(suppl 1):S103-7.
67. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995;41:1-4.
68. Rokkas T, Mavrogeorgis A, Liatsos C, Rallis E, Kalogeropoulos N. Optimal dose of omeprazole in combination with amoxicillin in eradicating H. pylori and preventing relapses in duodenal ulcer patients. Hepatogastroenterology 1995;42:842-6.
69. Nafeeza MI, Shahimi MM, Kudva MV, et al. Evaluation of therapies in the treatment of Helicobacter pylori associated non-ulcer dyspepsia. Singapore Med J 1992;33:570-4.
70. Mannes GA, Bayerdorffer E, Hochter W, et al. Decreased relapse rate after antibacterial treatment of Helicobacter pylori-associated duodenal ulcers. Munich duodenal ulcer trial. Eur J Gastroenterol Hepatol 1993;5:145-53.
71. Pallone F, Luzza F, Fave GD, et al. Lansoprazole and Helicobacter pylori infection. Clin Ther 1993;15:49-57.
72. Light RJ, Pillemer DB. Summing up - the science of reviewing research. Cambridge: Harvard University Press, 1984.
73. Hussar DA. Patient compliance. In: Gennaro AR, ed. Remington: the science and practice of pharmacy, 19th ed. Easton, PA: Mack, 1995:1813-84.
74. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Praybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
75. Medical Economics Company. Physicians' desk reference 1997. Montvale, NJ: Author, 1997.